<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03270787</url>
  </required_header>
  <id_info>
    <org_study_id>TCM1421</org_study_id>
    <nct_id>NCT03270787</nct_id>
  </id_info>
  <brief_title>Study of Compound Danshen Dripping Pills to Treat Acute Mountain Sickness</brief_title>
  <official_title>A Randomized, Double Blind, Placebo-controlled Study of Compound Danshen Dripping Pills in Preventing and Treating Acute Mountain Sickness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tasly Pharmaceuticals, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tasly Pharmaceuticals, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to evaluate the efficacy and safety of compound danshen dripping pills in&#xD;
      preventing and treating acute mountain sickness.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Compound danshen dripping pills is mainly used for the treatment and prevention of coronary&#xD;
      heart disease and high-risk groups ,consists of Danshen (Radix Salviae Miltiorrhizae), Sanqi&#xD;
      (Radix Notoginseng) and borneol.Danshen is the main drug efficacy of stasis, nourishing the&#xD;
      nerves.Pharmacological studies have shown that Danshen can improve the oxygen carrying&#xD;
      capacity of blood, increase oxygen supply to vital organs, effectively reduce hypoxia-induced&#xD;
      heart and other vital organs, brain and kidney damage. Danshen can activate the fibrinolytic&#xD;
      system, reduce blood viscosity, clear the microcirculation, promote blood circulation,&#xD;
      increasing the amount of tissue oxygen by inhibiting platelet aggregation.This study is being&#xD;
      conducted to evaluate the efficacy and safety of compound danshen dripping pills in&#xD;
      preventing and treating acute mountain sickness, when compared with placebo.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 24, 2016</start_date>
  <completion_date type="Actual">July 13, 2017</completion_date>
  <primary_completion_date type="Actual">July 13, 2016</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence of acute mountain sickness rapid radical to an altitude of 3000m above the plateau region compared to placebo</measure>
    <time_frame>7days</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">58</enrollment>
  <condition>Acute Mountain Sickness</condition>
  <arm_group>
    <arm_group_label>Placebo Comparator</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo Comparator: controlled group Placebo,10pills,tid,po</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Compound danshen dripping pills</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Compound danshen dripping pills Compound danshen dripping pills ,10pills,tid,po</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Drug: Placebo Placebo,10pills,tid,treat 1 weeks.</description>
    <arm_group_label>Placebo Comparator</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Compound danshen dripping pills</intervention_name>
    <description>Drug: Compound danshen dripping pills Compound danshen dripping pills,10pills,tid,treat 1 weeks.</description>
    <arm_group_label>Compound danshen dripping pills</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  aged 18-45 years，Male or female, plain natives&#xD;
&#xD;
          -  first stationed at high altitude above 3,000 meters&#xD;
&#xD;
          -  Upon physical examination before enrollment in good health&#xD;
&#xD;
          -  BMI 19 to 24; (weight kg / height Sqm )&#xD;
&#xD;
          -  voluntary signs the informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  menstruation, pregnancy and breast-feeding women&#xD;
&#xD;
          -  smoking, alcohol and drug abusers&#xD;
&#xD;
          -  Clear history of drug allergy or allergic persons&#xD;
&#xD;
          -  application of various drugs (including traditional Chinese medicine) two weeks ago&#xD;
&#xD;
          -  Combined with severe liver and kidney dysfunction (cardiac function Grade ≥3, liver&#xD;
             function Grade &gt; 2 times of the upper limit of normal, Cr&gt; upper limit of normal);&#xD;
&#xD;
          -  Subject with blood donation experiences or blood test experiences within three months&#xD;
             before be selected.&#xD;
&#xD;
          -  C- reactive protein test results exceed the upper limit of normal.&#xD;
&#xD;
          -  clinically significant gastrointestinal disease, mental illness and diabetes,&#xD;
             hyperthyroidism and other metabolic diseases;&#xD;
&#xD;
          -  Past suffering from cardiovascular and cerebrovascular disease&#xD;
&#xD;
          -  fatigue syndrome that is not by high altitude-induced&#xD;
&#xD;
          -  primary headache&#xD;
&#xD;
          -  Vomiting due to other causes, such as digestive disorders as a result of the vomiting&#xD;
             reflex, vomiting vestibular disorders, neurotic vomiting;&#xD;
&#xD;
          -  Allergies&#xD;
&#xD;
          -  Who participated in clinical trials of other drugs within a month&#xD;
&#xD;
          -  blood circulation, increase immunity and antioxidant drug users&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Min Zhao, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Tasly Group, Co. Ltd.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>People's Hospital of Tibet Autonomous Region</name>
      <address>
        <city>Damxung</city>
        <state>Tibet</state>
        <zip>850000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <study_first_submitted>June 23, 2016</study_first_submitted>
  <study_first_submitted_qc>August 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 1, 2017</study_first_posted>
  <last_update_submitted>August 30, 2017</last_update_submitted>
  <last_update_submitted_qc>August 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acute Mountain sickness</keyword>
  <keyword>Compound Danshen Dripping Pills</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Altitude Sickness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

